77 results
Page 3 of 4
6-K
EX-99.1
gxbhd2 j4
15 Jan 21
ERYTECH Announces First Patient Enrolled in Eryaspase in First-Line Pancreatic Cancer
12:35pm
6-K
EX-99.1
rzaobnjf wobowqw
15 Dec 20
ERYTECH Completes Enrollment in TRYbeCA-1
8:16am
6-K
EX-99
x2kpw8mpnhw1o1ny9n7u
7 Dec 20
Current report (foreign)
10:14am
6-K
EX-99.1
n79nc6h
6 Nov 20
ERYTECH Announces Abstract with Results from Eryaspase
9:24am
6-K
EX-99.2
26isb18
6 Nov 20
ERYTECH Announces Abstract with Results from Eryaspase
9:24am
6-K
EX-99.1
a1ytlc27a2ocl swn0aw
3 Nov 20
ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French Government
4:33pm
424B5
zytkddss
9 Oct 20
Prospectus supplement for primary offering
5:16pm
6-K
EX-99.2
7r8ce4b5gy
22 Sep 20
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020
12:00am
6-K
EX-99.1
3wy5pr
22 Sep 20
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020
12:00am
F-3
jh4ttl81tlyd8tcn5p5
21 Sep 20
Shelf registration (foreign)
5:26pm
6-K
EX-99.1
l69c3o
15 Sep 20
ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment
7:32am
6-K
EX-99.1
3beg akph7x
26 Jun 20
Current report (foreign)
5:10pm
6-K
EX-99.1
t32svk 9b
9 Jun 20
ERYTECH Provides Update on Phase 2 Investigator
4:11pm
6-K
EX-99.1
t5hsmv74o 3au
2 Jun 20
ERYTECH Announces Poster Presentations
5:07pm
6-K
EX-99.1
c3gnrf7
26 May 20
Erytech’s Combined Shareholders’ Meeting
4:40pm
6-K
EX-99.1
jf0lcy
8 May 20
ERYTECH Provides Business Update and Reports Cash Balance at End of Q1 2020
4:08pm
6-K
EX-99.1
9zc39 58wglpk42n5ahz
30 Apr 20
ERYTECH Granted U.S. FDA Fast Track Designation
7:59am
6-K
EX-99.1
f93 ait31020
21 Apr 20
ERYTECH Provides Update on theTRYbeCA-1
7:06am
6-K
EX-99.1
dnqdveq56bxce edrf
17 Mar 20
ERYTECH Announces the Appointment of
4:25pm